RESEARCH AS REMEDY

In Nursing and
Allied Health,
Recent Research
Promises Patient
Benefits
By Kevin Dunegan
Photography by Aaron Mayes and R. Marsh Starks
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During the past decade, UNLV’s Schools of Allied Health
Sciences and Nursing have expanded their research
programs and boosted collaboration among faculty
investigators in support of the university’s vision of
becoming a major research institution.
In Allied Health Sciences, these projects include a range
of potentially patient-benefitting areas, among them
investigations in health physics and diagnostic sciences,
physical therapy, nutrition, and kinesiology. Nursing
researchers are also working to improve human health
and wellness, most prominently via projects aimed at
advancing understanding of issues related to chronic
conditions such as diabetes, obesity, and stress. Both
schools will benefit from a recent $20 million grant from
NIH to support clinical and bench-to-bedside research and
to lead a health research group, the Clinical Translational
Research Infrastructure Network, or CTR-IN, comprising 13
universities across the Mountain West region.
The following profiles demonstrate the diversity and
depth of the two schools’ research projects.
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Yu Kuang:
Dangerous Tumors,
Expedited
Assessments
YU KUANG, AN ASSISTANT PROFESSOR
in the School of Allied Health Sciences, is focused on the early detection of cancer and image-guided cancer treatment. His recent work
explores whether testing for genetic markers
associated with tumors, coupled with new approaches to quantitative magnetic resource
imaging (MRI) analysis, might lead to more
effective treatments for sarcomas, malignant
tumors that form in bone, cartilage, fat, muscle, or vascular tissue.
Patients diagnosed with sarcoma usually
undergo what health care providers call “neoadjuvant” therapy — typically chemotherapy
— to shrink their tumors before surgery.
Reducing tumor size prior to operating, oncologists have found, not only makes surgery
more effective but also enhances patients’
long-term survival rates.
A drawback of this approach is that determining whether neoadjuvant therapy has
done its job can only happen via tumor-tissue
analysis following surgery. This means that
patients don’t learn if they’ve benefitted until after leaving the operating room, an unfortunate reality that ensures some patients
will endure the toxic effects of chemotherapy
without any therapeutic advantage. For these
patients, the harm in superfluous chemo is
not just in the unnecessary discomfort it inflicts. Precious time has been wasted — time
that could have been spent on potentially lifesaving treatment alternatives.
Kuang has teamed up with the Children’s
Specialty Center of Nevada and Nevada Imaging Centers to develop an earlier, non-invasive method for predicting success or failure
of neoadjuvant chemotherapy. His method involves combining an analysis of tumor markers in mitochondrial DNA from blood draws
and diffusion MRI data. The goal, Kuang says,
is to identify the early changes of genetic biomarker levels in the blood and the imaging
features in the MRI scan that can help clinicians more effectively ascertain how well sarcomas have responded to pre-operative chemotherapy.
By determining patients’ response to the
treatment early in the course of chemother-
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apy, Kuang’s team expects this research will
ultimately enable oncologists to optimize
treatment protocols for individual patients,
improving quality of life and enhancing disease-free survival for patients with sarcoma.
If successful, Kuang’s next step will likely
involve multi-institutional clinical trials.
These will seek to determine how this combined biological- and imaging-biomarker
method might be used to guide future chemotherapy treatments.
Kuang is also actively involved in multiinstitutional collaborative work related to
prostate cancer. Earlier this year, he teamed
up with Sandi A. Kwee, a physician and associate professor at the John A. Burns School
of Medicine at the University of Hawaii, to de-

velop a positron emission tomography (PET)
image guided prostate cancer radiation therapy method. PET scan is an imaging test that
helps reveal how patients’ tissues and organs
are functioning via a radioactive drug (radiotracer). In this collaboration, the radiotracer
Kuang and Kwee are using is a new U.S. Food
and Drug Administration-approved investigational drug that could allow for better targeting of radiation treatments used against intermediate- and high-risk prostate cancer.
The collaborative relationship is expected
to lead to a multicenter clinical trial initiative
between UNLV and University of Hawaii, a
trial that could bring this potentially gamechanging approach to prostate cancer patients in Southern Nevada.

ACCELERATED ANSWERS A diagnostic tool developed in part by UNLV’s Yu Kuang promises to speed physicians’
ability to assess the effectiveness of neoadjuvant therapy in sarcoma patients. If successful, the approach could
lead to new, more effective ways to combat these potentially deadly malignancies.
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SHOCK AND STRESS The human knee
takes a continual pounding, a process
scientists such as UNLV’s Kai-Yu Ho
describe as “shock loading.” Ho’s
latest research aims to identify how
shock-loading stress on knees may be
contributing to arthritis-inducing bone
alignment issues.

Kai-Yu Ho: Assessing
“Shock-Loading” and
Arthritis Risks
OSTEOARTHRITIS OF THE KNEE, AN INcreasingly common health problem among
active adults, is a painful condition involving loss of cartilage and deformity of the
joint. It is also a major factor in diminished
mobility, especially among older people.
Multiple studies have identified stress injuries to the leg bones as a primary contributor to arthritic knee pain and deformity. Lit-
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tle is known, however, about the causes and
progression of bone-stress injuries among
middle-aged, active adults.
Kai-Yu Ho, an assistant professor in the
School of Allied Health Sciences, is directing
a study that could remedy this deficiency,
while at the same time providing a method
for evaluating the probability that osteoarthritis is present. She also hopes to help
doctors detect the sort of bone damage that
produces osteoarthritis, even before a person
experiences pain.
Ho’s study involves an examination of
how “locomotion-induced shock loading” —
the results of such everyday, bone-jarring
movement like walking, running, and stair
climbing — affects the physiology of knees.
Her work also examines the alignment of

bones in legs that have stress injuries, and
how injury-related alignment issues might
relate to arthritis development.
A normal femur, or upper leg bone, is not
perfectly vertical. The bone extends from the
hip at a slight angle toward the midline of
the body. Normal physical activity can cause
micro-damage to the femur and tibia where
they meet at the knee. The body repairs the
damage by growing new bone, a process
called bone remodeling.
Continual shock-loading damage can
cause too much bone remodeling, however,
with new bone forcing the femur away from
the midline of the body into a “varus angle”
(a phrase adapted from the Latin word for
“crooked”). When the varus angle is pronounced a person appears bowlegged — the
knees do not touch when one stands with his
or her feet together.
Ho hypothesizes that increased shock
loading among middle-aged persons will
lead to greater bone stress, which can increase the onset of osteoarthritis in the joint.
She put her hypothesis to the test in a study
involving 20 adults ranging in age from 50
to 65. None of her subjects had been diagnosed with arthritis in the knee.
Participants were asked to complete a
locomotion-induced, shock-loading activity.
When finished, they receive a magnetic resonance imaging (MRI) scan to verify bone
stress injuries. Participants next allowed the
researchers to measure the angle between
the long axis of their femurs and tibias.
Ho says she and her team are now analyzing the data they’ve collected to determine
whether there is an association between lower extremity alignment and MRI-detected
bone stress injury. If there is, she says, the
finding could provide health-care providers
with an early detection method of bone abnormalities. This, in turn, will enable them
to recommend physical therapy intervention
to ward off future bone-stress injuries to patients’ knees.
Research related to this study has been
published in the European Journal of Sports
Science and Magnetic Resonance Imaging.
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INJURY AND OXYGEN When soldiers and others
experience “crush injuries,” their treatment often
includes evacuation by air. UNLV’s Barbara St. Pierre
Schneider is exploring why the cabin pressure during
such flights may be harmful and what to do about it.

Barbara St. Pierre
Schneider: Enhanced
Care After Extreme
Compressions
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EARTHQUAKES, EXPLOSIONS, INDUSTRIAL
accidents, car crashes — each are forms of
mayhem that leave crushing trauma in their
wake. Barbara St. Pierre Schneider, an associate professor in the School of Nursing, is
working to better understand the biological
processes characterizing such “skeletal and
muscle-crush injuries,” and how they might
best be treated. She is especially concerned
with U.S. service personnel who have been
injured on the battlefield.
Whether these injuries occur in military
combat, during a terrorist attack, or in a natu-

ral disaster, crush-related injuries involve significant compression, a traumatic event that
interrupts blood flow and damages the cell
membrane of muscle fibers. Although the injury itself may not be immediately life threatening, damaged muscle can increase the risk
for death down the road: In many cases ruptured muscles spill cellular contents, such as
the muscle protein myoglobin, into the bloodstream. Myoglobin, for example, can cause
kidney damage and failure.
Soldiers who experience skeletal musclecrush injuries during combat face additional
challenges. Often, the wounded must endure
long flights to treatment centers. While unavoidable, these evacuations by air expose the
wounded to hypobaria, a situation in which
tissues may be deprived of sufficient oxygen,
which can become a factor when the air pressure is equivalent to an altitude of 8,000 feet,
or that of a typical plane’s cabin pressure.
St. Pierre Schneider and her team are studying how hypobaric hypoxia affects the healing
of injuries and are searching for potential treatments that counteract its effects. A previous St.
Pierre Schneider study, for example, simulated
the effects of air transport and examined the
effect of hypobaric hypoxia on genes within
skeletal muscle. One major finding was that the
simulated flights affected the genes affiliated
with skin integrity, but had no apparent effect
on inflammatory genes in skeletal muscle.
To further her hyperbaric hypoxia crushmuscle research, St. Pierre Schneider is expanding the capabilities of her lab. She recently received grant funding to purchase
a combined cell sorter/flow cytometer, an
instrument that allows scientists to measure
and analyze the inner workings of cells. Having the instrument, says St. Pierre Schneider,
will enhance UNLV’s research capacity and
the university’s science, technology, engineering, and mathematics (STEM) program.
St. Pierre Schneider’s studies in muscle injury recovery are guiding techniques in aeromedical evacuation, and her work has been
featured in multiple publications, including
Aviation, Space and Environmental Medicine
and Innate Immunity.
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A PLAN FOR PAIN UNLV’s Jennifer Kawi is helping both
back-pain sufferers and their doctors embrace new
ways of thinking about managing the condition. It’s
an approach that promises to boost patient outcomes
while reducing healthcare costs.

Jennifer Kawi:
Self-Service
for Back Pain

WHEN IT COMES TO PAINFUL CONDITIONS
affecting the mobility of millions of Americans, bum knees take a back seat to bad backs.
Chronic low-back pain is the most common
health complaint in the United States, afflicting nearly 30 percent of people older than
18. In addition to the physical discomfort it
causes, chronic low-back pain sufferers also
incur high health care costs.
In recent years, more physicians and specialists have recommended self-management
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strategies to help reduce pain, improve quality of life, and lower associated treatment
costs. Jennifer Kawi, a chronic pain specialist and assistant professor in the School of
Nursing, is among those who have noted its
effectiveness, and she is currently working to
identify those chronic low-back pain sufferers
who might benefit.
In general, self-management strategies not
only encourage patients to actively direct and
improve their health, but they also inspire and
reinforce patient confidence. Such positive feelings, Kawi says, help patients set realistic goals
and action plans, and make lifestyle changes
that often include increased exercise and activity levels, better eating habits, and greater use
of non-pharmacological pain remedies such as
heating wraps and relaxation techniques.
While self-management has improved
outcomes and lowered health care costs for
a host of conditions, its effectiveness with
chronic low-back pain sufferers has not been

fully explored. Kawi’s project aimed to remedy this using a two-pronged approach.
She first sought to identify variables, such
as perceived support from health care providers, pain intensity, and functional ability, that
might predict which low-back pain sufferers
would respond best to self-management strategies. Her second goal involved evaluating
differences in those variables among patients
seeking help in specialty pain centers and primary care clinics. Understanding these variables, she reasoned, could help maximize selfmanagement effectiveness in clinical settings,
while enabling health care providers to tailor
self-management strategies to fit the needs of
individual patients.
Kawi and her team analyzed data from 230
people with chronic low-back pain — 110
from specialty pain centers and 120 from primary care clinics. Her research revealed five
variables to be predictors of self-management
for patients in both settings: age, self-management support, education levels, overall health,
and the helpfulness of pain management.
She also discovered differences among key
variables in patients who sought care from a
specialty pain center versus those who sought
care in a primary care clinic. For example,
participants in specialty pain centers were
more apt to self-manage if they were active in
their religious or spiritual beliefs or if they received support from their significant others.
On the other hand, low-back pain patients in
primary care clinics who had higher incomes
tended to self-manage more than those with
lower incomes. These important preliminary
findings have been tabbed for future research.
Kawi’s research has already provided essential intervention data that health care providers can use to bolster the odds that chronic
low-back pain patients will be able to successfully self-manage their conditions. The results
also identified a need to formulate additional
strategies for patients who may not be the best
candidates for self-management programs.
The study, which was funded by an external grant from the Nurse Practitioner Healthcare Foundation, appeared in the journal Applied Nursing Research.
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Susan VanBeuge:
For Ailing Seniors,
Coordinated Solutions
PEOPLE OFTEN FACE MULTIPLE CHRONIC
ailments during their senior years, clusters of
conditions that demand a collaborative approach to treatment. But today there are few, if
any, training opportunities aimed at preparing
the next generation of practitioners and specialists for the challenges of providing the collaborative, interprofessional elder care that is so
desperately needed.
Susan VanBeuge is changing that.
VanBeuge is an assistant professor in the
School of Nursing who is co-principal investigator with Georgia Dounis, an associate professor
of clinical sciences in UNLV’s School of Dental
Medicine, and Sue Schuerman, an assistant professor in the School of Allied Health Sciences.
The UNLV team is a sub-awardee of the Nevada
Geriatric Education Consortium, a state-wide
initiative aimed at improving the health care
delivered to older adults.
The UNLV objectives include developing a
Type 2 diabetes management training program
for interprofessional faculty with emphasis on
communication, prevention of co-morbidities,
and cultural sensitivity.
At its core, VanBeuge’s program aims to develop a series of provider training for senior
health issues to include Type 2 diabetes and
Alzheimer’s disease. The UNLV team, for example, has developed a one-day training program
focused on Type 2 diabetes and offered it statewide to health care providers and faculty who
work with professional students. The program
includes video-recorded encounters with “standardized” patients — individuals trained to simulate the needs of real patients — and hands-on
training with high-fidelity manikins.
The program focused on Type 2 diabetes
because of its multiple symptoms, prevalence
among older adults, and the need for multiple
health care professionals to involve themselves in treatment and management of the
condition.
During the training, each participant received a chart detailing a standardized pa-

tient’s medical and social history, physical
attributes, clinical findings, and chief complaint. Teams had 15 minutes to complete
the examination. During the encounter, each
group assessed their patient’s physical status,
formulated treatment goals and intervention
options, noted potential outcomes, and identified opportunities for coordination of care.
They also developed a plan for how responsibility for that care would transpire.
The teams next participated in a debriefing
session with the project’s instructors (who
were observing the interactions in real time
on video monitors). Finally, instructors led a
group discussion and encouraged self-assessments from participants.
Thus far, the five-year grant, now in its fourth

year, has seen close to 100 participants complete
the course. Early findings were published after
the study’s second year. Participants at that time
told the researchers that they had gained a better understanding of inter-professional team
building, a stronger ability to communicate effectively with team members, and greater confidence in recognizing that meeting the needs of
geriatric patients often requires an interprofessional response.
The project has been featured in the Journal of Interdisciplinary Healthcare and has
been presented during multiple national clinical conferences. The team recently received
additional funding to include Alzheimer’s disease and dementia to the course training for
the coming year.

COLLABORATIVE CARE Managing Type 2 diabetes
and Alzheimer’s disease is one of senior care’s
greatest challenges. UNLV’s Susan VanBeuge leads a
team that is teaching a more coordinated approach.
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Steen Madsen:
A Nano-Sized Weapon
Against Glioblastoma

SCHOOL OF ALLIED HEALTH SCIENCES’
Steen Madsen is exploring new treatment
methods for primary brain tumors — tumors that originate in the brain — using
nanoparticles and lasers.
Madsen, professor and chair for the department of health physics and diagnostic
sciences, is collaborating with Henry Hirschberg, a researcher at the University of California-Irvine’s Beckman Laser Institute and
Medical Clinic, on a particularly promising
approach. It involves using a type of white
blood cell that ingests foreign material as a
therapeutic-drug delivery vehicle.
There are approximately 34,000 new cases
of primary brain tumors diagnosed each year
in the U.S. and Europe. Close to 40 percent
of these tumors are of the most aggressively
malignant variety, glioblastoma multiforme
(GBM). Less than 5 percent of patients diagnosed with GBM will live more than five years.
Glioblastoma tumors are notoriously aggressive and difficult to treat. When removed during surgery, they almost always reappear. Madsen, Hirschberg, and their research team are
exploring a small solution to this big problem:
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employing macrophages, the aforementioned,
material-ingesting white blood cells, to transport nano-sized particles of therapeutic gold to
surgical resection sites. If successful, it’s a system that could greatly enhance the effectiveness of photothermal therapy, a process that
destroys tumor cells using laser light.
Why gold? The precious metal offers two
particular advantages. First, it has already
been used safely in humans for a variety
of medical applications. Second, and more
to the point, gold has the ability to convert
infrared laser energy to thermal energy.
When exposed to photothermal therapy,
gold nanoparticles act as heat generators and
burn the tumor cells.
In preliminary studies, Madsen and Hirschberg demonstrated the feasibility of using macrophages as delivery vehicles for gold-based
nanoparticles. This was a particularly welcome
finding given that, being part of the body’s
natural defenses, macrophages can be easily extracted from a patient, loaded with the desired
therapeutic agents and re-injected into the body.
During the study’s next phase, Madsen and
Hirschberg’s team showed that using gold-

MASTERING MACROPHAGES A new, nano-particlebased drug delivery system being developed by
UNLV’s Steen Madsen offers hope against primary
brain tumors.

loaded macrophages in concert with photothermal therapy was effective in treating tumor cells in the brains of laboratory animals.
Animals that received the macrophages and
photothermal therapy, in fact, showed zero
tumor cells when the treatments concluded.
These findings and others have been published in the Annals of Biomedical Engineering and Lasers in Surgery and Medicine.
Hurdles remain, however. Part of Madsen
and Hirschberg’s current research involves
searching for a means to allow nanoparticleloaded macrophages to pass through the
body’s “blood-brain barrier,” the biological
mechanism preventing most external cells
and other matter from passing through to the
brain. Thus far, the answer has eluded them.
Madsen and Hirschberg say they are confident that this obstacle, too, can be overcome,
and that, once bypassed, they will be that
much closer to improving the dismal five-year
survival rate of GBM patients.
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